Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients.
Marina MacchiniUmberto PerettiGiulia OrsiSilvia ZanonElena MazzaMaria Maddalena ValenteDomenico TamburrinoGiulio BelfioriGemma RossiSabrina Gloria Giulia TestoniPaolo PassoniClaudio DoglioniStefano CascinuMichele ReniPublished in: Cancer chemotherapy and pharmacology (2020)
Our data endorse the strategy of resuming prior drugs after a chemotherapy holiday ≥ 3 months in advanced PDAC patients who achieved a durable disease control after upfront treatments.